Ventolin
Product Images NDC 54868-6050

11 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ventolin (NDC 54868-6050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label (6050)

Image Of Package Label (6050)
A packaging label for VENTOLIN HFA Inhaler distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes the NDC 54868-6050-0, lot number 0000, and an expiration date of 01/60. Manufactured by GlaxoSmithKline, Research Triangle, NC. A barcode is also present at the bottom of the label.*
FDA Label Image

Albuterol Sulfate Chemical Structure (E33e8998 F335 4661 886b 6f553569c9a6 01)

Albuterol Sulfate Chemical Structure (E33e8998 F335 4661 886b 6f553569c9a6 01)
Chemical structure of the active ingredient shown with a benzene ring, hydroxyl groups, a side chain including an amine group, and two sulfuric acid (H2SO4) units, likely representing albuterol sulfate in the product VENTOLIN HFA.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)
A line chart comparing the mean percentage change from baseline in a variable over time (hours) for three inhalation treatments, including VENTOLIN HFA administered as 2 inhalations 4 times daily, CFC 11/12-propelled albuterol, and HFA-134a placebo inhaler. The chart shows data points from 0 to 8 hours.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)
A line graph comparing mean change from baseline in peak expiratory flow over 6 hours among different inhaler treatments, including VENTOLIN HFA 2 inhalations 4 times daily. The x-axis represents time in hours, and the y-axis shows mean change from baseline in liters per minute.*
FDA Label Image

Figure 1 (E33e8998 F335 4661 886b 6f553569c9a6 04)

Figure 1 (E33e8998 F335 4661 886b 6f553569c9a6 04)
An instructional line drawing illustrating the components of a metered-dose inhaler, including the metal canister, plastic actuator, mouthpiece, cap, counter, and strap. The diagram clearly labels each part of the device, providing a visual guide for understanding its structure.*
FDA Label Image

Figure 2 (E33e8998 F335 4661 886b 6f553569c9a6 05)

Figure 2 (E33e8998 F335 4661 886b 6f553569c9a6 05)
Illustration showing the mouthpiece-down position of an inhaler labeled VENTOLIN HFA. The diagram highlights parts of the inhaler including the mouthpiece, strap, and cap, demonstrating how to hold the device for proper use.*
FDA Label Image

Figure 3 (E33e8998 F335 4661 886b 6f553569c9a6 06)

Figure 3 (E33e8998 F335 4661 886b 6f553569c9a6 06)
An instructional illustration showing a person holding a VENTOLIN HFA inhaler near the mouth, demonstrating proper use by pushing down on the inhaler and breathing in to inhale the medication.*
FDA Label Image

Figure 4 (E33e8998 F335 4661 886b 6f553569c9a6 07)

Figure 4 (E33e8998 F335 4661 886b 6f553569c9a6 07)
An instructional diagram showing two metered-dose inhalers, one held in a hand and the other resting on a surface. The illustration appears to demonstrate proper handling or preparation of the inhaler, likely related to the VENTOLIN HFA product.*
FDA Label Image

Figure 5 (E33e8998 F335 4661 886b 6f553569c9a6 08)

Figure 5 (E33e8998 F335 4661 886b 6f553569c9a6 08)
An instructional illustration showing a hand holding a VENTOLIN HFA inhaler under running water from a faucet, demonstrating the cleaning process of the inhaler mouthpiece. The inhaler is held horizontally, and water is shown spraying onto it.*
FDA Label Image

Figure 6 (E33e8998 F335 4661 886b 6f553569c9a6 09)

Figure 6 (E33e8998 F335 4661 886b 6f553569c9a6 09)
The illustration shows a sequence demonstrating the preparation and use of an inhaler device. The top section depicts a person’s mouth with lips around the inhaler mouthpiece. The bottom section shows two inhalers, with one cap removed and the mouthpiece exposed, indicating how to hold and use the device for inhalation.*
FDA Label Image

Figure 7 (E33e8998 F335 4661 886b 6f553569c9a6 10)

Figure 7 (E33e8998 F335 4661 886b 6f553569c9a6 10)
An instructional illustration showing two views of an inhaler labeled VENTOLIN HFA. The top image depicts the inhaler with an open mouthpiece and medication spray labeled 'Not Blocked.' The bottom image shows the mouthpiece covered or blocked, with the medication spray obstructed, labeled 'Blocked.' This diagram demonstrates correct and incorrect inhaler use regarding mouthpiece obstruction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.